Galecto News

Galecto Is Maintained at Outperform by Oppenheimer

Dow JonesOct 17, 2024 09:32 ET

Galecto Analyst Ratings

BenzingaOct 17, 2024 09:22 ET

Oppenheimer Maintains Galecto(GLTO.US) With Buy Rating, Cuts Target Price to $10

Moomoo NewsOct 17, 2024 08:34 ET

Oppenheimer Sticks to Its Buy Rating for Galecto (GLTO)

TipRanksOct 17, 2024 08:09 ET

Galecto Analyst Ratings

BenzingaJun 10, 2024 07:20 ET

Oppenheimer Remains a Buy on Galecto (GLTO)

TipRanksNov 16, 2023 07:55 ET

H.C. Wainwright Sticks to Their Hold Rating for Galecto (GLTO)

TipRanksOct 24, 2023 06:28 ET

Analysts Offer Insights on Healthcare Companies: Galecto (GLTO), Encompass Health (EHC) and Caribou Biosciences (CRBU)

TipRanksSep 28, 2023 06:40 ET

Galecto Analyst Ratings

BenzingaSep 28, 2023 06:21 ET

Analysts Are Bullish on Top Healthcare Stocks: Galecto (GLTO), Amylyx Pharmaceuticals Inc (AMLX)

TipRanksAug 21, 2023 06:40 ET

HC Wainwright & Co. Maintains Buy on Galecto, Lowers Price Target to $2

BenzingaAug 21, 2023 06:26 ET

Galecto Analyst Ratings

BenzingaAug 21, 2023 06:26 ET

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Galecto (GLTO) and Cardinal Health (CAH)

TipRanksAug 15, 2023 21:10 ET

Galecto Analyst Ratings

BenzingaAug 15, 2023 10:41 ET

Galecto (GLTO) Receives a Buy From H.C. Wainwright

TipRanksAug 1, 2023 06:25 ET

HC Wainwright & Co. Reiterates Buy on Galecto, Maintains $12 Price Target

BenzingaAug 1, 2023 06:23 ET

Galecto Analyst Ratings

BenzingaAug 1, 2023 06:22 ET

Oppenheimer Initiates Coverage On Galecto With Outperform Rating, Announces Price Target of $12

BenzingaJun 20, 2023 04:56 ET

HC Wainwright & Co. Reiterates Buy on Galecto, Maintains $12 Price Target

BenzingaMay 24, 2023 06:39 ET

Analysts Offer Insights on Healthcare Companies: Galecto (GLTO), Bioxcel Therapeutics (BTAI) and Wave Life Sciences (WVE)

TipRanksMay 24, 2023 06:30 ET